Alembic Limited
Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based … Read more
Alembic Limited (ALEMBICLTD) - Total Liabilities
Latest total liabilities as of September 2025: ₹1.91 Billion INR
Based on the latest financial reports, Alembic Limited (ALEMBICLTD) has total liabilities worth ₹1.91 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Alembic Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Alembic Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Alembic Limited Competitors by Total Liabilities
The table below lists competitors of Alembic Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mewah International Inc
F:MWX
|
Germany | €1.19 Billion |
|
FingerMotion Inc
NASDAQ:FNGR
|
USA | $43.71 Million |
|
Eolus Vind AB (publ)
ST:EOLU-B
|
Sweden | Skr983.00 Million |
|
Indústrias Romi S.A
SA:ROMI3
|
Brazil | R$1.35 Billion |
|
Jayamas Medica Industri
JK:OMED
|
Indonesia | Rp390.05 Billion |
|
Sun Max Tech Ltd
TW:6591
|
Taiwan | NT$1.29 Billion |
|
Adagene Inc
NASDAQ:ADAG
|
USA | $28.61 Million |
|
THN Corporation
KO:019180
|
Korea | ₩387.13 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Alembic Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.02 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alembic Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alembic Limited (2004–2025)
The table below shows the annual total liabilities of Alembic Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹1.64 Billion | +14.80% |
| 2024-03-31 | ₹1.43 Billion | +13.17% |
| 2023-03-31 | ₹1.27 Billion | -6.52% |
| 2022-03-31 | ₹1.35 Billion | +20.94% |
| 2021-03-31 | ₹1.12 Billion | +112.49% |
| 2020-03-31 | ₹526.78 Million | -8.10% |
| 2019-03-31 | ₹573.20 Million | -21.77% |
| 2018-03-31 | ₹732.75 Million | -9.48% |
| 2017-03-31 | ₹809.47 Million | +11.85% |
| 2016-03-31 | ₹723.70 Million | -26.52% |
| 2015-03-31 | ₹984.89 Million | -21.51% |
| 2014-03-31 | ₹1.25 Billion | -9.17% |
| 2013-03-31 | ₹1.38 Billion | -28.91% |
| 2012-03-31 | ₹1.94 Billion | -64.47% |
| 2011-03-31 | ₹5.47 Billion | -17.06% |
| 2010-03-31 | ₹6.59 Billion | -3.63% |
| 2009-03-31 | ₹6.84 Billion | +13.20% |
| 2008-03-31 | ₹6.04 Billion | +20.82% |
| 2007-03-31 | ₹5.00 Billion | +44.64% |
| 2006-03-31 | ₹3.46 Billion | -0.85% |
| 2005-03-31 | ₹3.49 Billion | +1.03% |
| 2004-03-31 | ₹3.45 Billion | -- |